Tradestie Institutional Equity Comparison Engine

FLGT vs IMDX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

FLGT Overall Edge

FLGT Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Fulgent Genetics, Inc. Common Stock (FLGT) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, FLGT trades at 7.7x Forward P/E with -37.1% operating margin (+7.5% YoY revenue) versus IMDX at N/M Forward P/E and -1883.2% operating margin (+115.0% YoY). In options structure, FLGT sits in BREAKOUT (9th %ile IV; Dealer Gamma Walls on Pro) against IMDX sits in BREAKDOWN (12th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner FLGT
FLGT 7.7x vs IMDX N/M Fwd P/E
Growth & Margin Winner FLGT
Op Margin -37.1% vs -1883.2% ยท YoY +7.5% vs +115.0%
Momentum & Technical Winner FLGT
1Y -14.8% vs -73.8% ยท 52W Pos 64% vs 3%
Options & Structure Winner FLGT
BREAKOUT (9th %ile IV) vs BREAKDOWN (12th %ile IV)
FLGT NASDAQ
Fulgent Genetics, Inc. Common Stock
Services-Medical Laboratories
$24.78
-1.39% 1D
Market Cap $708.5M
1M Return +23.1%
1Y Return -14.85%
Forward P/E 7.7x
Unified AI Score
33.7 / 100 SELL
Tech 50.0 Fund 32.0 Flow 58.0 Mom 50.0
IMDX NASDAQ
Insight Molecular Diagnostics Inc. Common Stock
In Vitro & In Vivo Diagnostic Substances
$1.66
+4.4% 1D
Market Cap $52.1M
1M Return -45.03%
1Y Return -73.78%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 50.0 Fund 40.0 Flow 58.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: FLGT -14.85% IMDX -73.78% Spread: +58.93 pp (FLGT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period FLGT Revenue IMDX Revenue FLGT Op. Margin IMDX Op. Margin Margin Edge
FY2018 $20M N/A -23.7% N/A FLGT
FY2019 $30M N/A -1.3% N/A FLGT
FY2020 $420M $0M 68.8% -2443.3% FLGT
FY2021 $990M $0M 68.1% -2444.3% FLGT
FY2022 $620M $0M 28.8% -1878.6% FLGT
FY2023 $290M $0M -67.6% -1672.4% FLGT
FY2024 $280M $0M -26.1% -3245.1% FLGT
FY2025 $320M $0M -28.2% -1260.8% FLGT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: FLGT (6) vs IMDX (4)
Institutional Metric FLGT IMDX Criterion Row Winner
Market Capitalization Scale $708.5M $52.1M Larger Scale FLGT
Trailing P/E Ratio Valuation 7.7x N/M Lower Multiple FLGT
Forward P/E Ratio Valuation 7.7x N/M Lower Multiple FLGT
Revenue Growth (YoY) Growth +7.5% +115.0% Higher Growth IMDX
Operating Margin (TTM) Profitability -37.1% -1883.2% Higher Margin FLGT
Net Profit Margin Profitability -27.5% 0.0% Higher Margin IMDX
Return on Equity (ROE) Capital Efficiency -8.7% -23603.1% Higher ROE FLGT
52-Week Range Position Momentum 64% ($13โ€“$31) 3% ($2โ€“$8) Stronger Trend FLGT
Beta / 30D Volatility Risk Regime 1.13ฮฒ ยท 108% Vol 2.91ฮฒ ยท 76% Vol Lower Realized Risk IMDX
Unified Institutional Score Composite Signal 33.7 / 100 (SELL) 45.5 / 100 (HOLD) Higher Composite IMDX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full FLGT vs IMDX Buy Guide
FLGT BREAKOUT
97d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live FLGT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMDX BREAKDOWN
117d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live IMDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither FLGT nor IMDX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.